Huge Deal. Some takeaways from me:
- Massive validation from a US $26B International Tech Company.
- Strategic investment. These guys will be sticky, no dumping on market after a quick 20% gain. Also the potential for them to take further stakes or even take over the whole company.
- Excellent cash runway. Approx $23m in cash with the potential for more grants. No dilution for a while.
- No 6% broker fees or options granted, deal done direct with Keysight at a favourable price.
- Any institutions or fund managers waiting for a raise will now be forced to buy on market.
- Founder led business with significant skin in the game. Well done Scott Kirkland and team.
- Forums
- ASX - By Stock
- EMV
- Ann: Strategic A$15.28M Investment from Keysight Technologies
EMV
emvision medical devices ltd
Add to My Watchlist
0.00%
!
$1.75

Ann: Strategic A$15.28M Investment from Keysight Technologies, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.75 |
Change
0.000(0.00%) |
Mkt cap ! $149.6M |
Open | High | Low | Value | Volume |
$1.75 | $1.75 | $1.75 | $445 | 254 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5500 | $1.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 3600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5500 | 1.750 |
1 | 576 | 1.735 |
1 | 4000 | 1.725 |
1 | 132 | 1.720 |
4 | 10746 | 1.705 |
Price($) | Vol. | No. |
---|---|---|
1.795 | 3600 | 1 |
1.800 | 6575 | 2 |
1.810 | 1350 | 1 |
1.840 | 3000 | 1 |
1.845 | 1700 | 1 |
Last trade - 11.37am 04/07/2025 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online